Here are relevant reports on : blood-collection-needles-market
-
Blood Warmer Devices/Sample Warmer Market by Sample (Blood, Embryo, Ovum, Semen), End User (Hospital, Blood Bank, Transfusion Center, Tissue Bank), Region (North America, Europe, Asia Pacific) & Geography
The blood warmer devices market is projected to grow at a CAGR of 8.4%. Some of the prominent players in the market are 3M (US), BD (US), The 37Company (Netherlands), Geratherm Medical (Germany), Stryker (US), Sarstedt (Germany), Barkey (Germany), Stihler Electronic (Germany), Belmont instrument (US), Biegler (Austria), and EMIT (US).
- Published: November 2017
- Price: $ 4950
- TOC Available:
-
Capillary Blood Collection Market by Device Type (Lancing Devices), Source (Infants and Young Children, Elderly Patient), Application (Point-Care-Testing, Blood Examination), & End User (Hospital, Diagnostic Centers, Blood Bank) - Global Forecast to 2023
The global capillary blood collection market is expected to reach USD 1.64 million by 2023 from USD 1.27 billion in 2018, growing at a CAGR of 5.2%. The rising number of surgeries, increasing incidences and prevalence of various diseases and technological advancement are some of the major factors driving the growth of the global capillary blood collection market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Blood Glucose Monitoring Devices Market by Product [Blood Glucose Meters, Continuous Glucose Monitoring Systems (Sensors, Transmitter), Glucose Monitoring Strips, Lancets], Application (Hospitals, Diagnostics, Home Settings) - Global Forecasts to 2019
The global blood glucose monitoring devices market is expected to grow at a significantly high rate in the next five years. Global rise in the prevalence and incidence of diabetes and increasing adoption of continuous glucose monitoring (CGM) systems are the key factors propelling the growth of this market. In addition, continuous technological advancements in blood glucose monitoring devices and rapid growth in aging population are further stimulating the demand for blood glucose monitoring devices. However, inadequate reimbursement and high cost associated with the application of CGM systems and product recalls are some of the key factors hampering the growth of this market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024
The global patient blood management market size is expected to grow USD 15.3 billion by 2024, at a CAGR of 7.4% during the forecasting period. The major players in the market include Haemonetics Corporation (US), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (US), B. Braun Melsungen AG (Ireland), Macopharma (US), bioMérieux SA (France), Asahi Kasei Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Grifols, S.A. (Spain), F. Hoffmann-La Roche LTD (Switzerland), LivaNova PLC (UK), Danaher Corporation (US), Mediware Information Systems (US), Kawasumi Laboratories, Inc. (Japan), Haier Biomedical (China), Diatron (Hungary), and BAG Diagnostics GmbH (Germany), among others.
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Food Intolerance Test Market by Test Type (Conventional (Skin (Scratch, Intradermal, Patch), Blood (Elisa, Rast)), Alternative Allergy (Non Invasive (Hair, Kinesiology), Invasive (Igg Blood, Electro-Dermal, Cytotoxic, Microarray))) - Global Forecast to 2020
Food intolerance is a non-allergic hypersensitivity to a food product. It is caused when an incompletely digested food enters into a bloodstream. It is usually either due to lack of required enzyme to digest food or inability to absorb a digested food. Food intolerance testing is needed to assess digestion capability and suggest appropriate diet.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, CLIA, Rapid Tests), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Endocrinology), End User (Hospitals & Clinics, Blood Banks) & Region - Global Forecast to 2028
The global immunoassay market in terms of revenue was estimated to be worth $35.0 billion in 2023 and is poised to reach $46.7 billion by 2028, growing at a CAGR of 5.9% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market Size, Share & Trends by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The size of global exosome diagnostics and therapeutics market in terms of revenue was estimated to be worth $59 million in 2024 and is poised to reach $6,848 million by 2032, growing at a CAGR of 81.2% from 2024 to 2032. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Blood Screening Market by Product (Reagent & Kits, Instrument, Software), Technology (NAT, (Real-Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), End User (Blood Bank, Hospital), & Region - Global Forecast to 2028
The global blood screening market in terms of revenue was estimated to be worth $2.4 billion in 2023 and is poised to reach $3.4 billion by 2028, growing at a CAGR of 7.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Human Insulin Market By Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes)
The global human insulin market size is projected to grow at a CAGR of 8.1%. Market growth can be attributed to factors such as growing diabetes patient population, increasing population exposure to key risk factors leading to diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery devices, and favorable medical reimbursements. However, stringent regulatory requirements for product approval are restraining the growth of this market.
- Published: December 2015
- Price: $ 4950
- TOC Available:
-
Tissue Dissection Market by Method (Blunt, Sharp, Diathermy), Technology (Ultrasound, Electrosurgery, Hydromechanical, Pneumodissection), Product (Scissors, Needles, Hammers, Laser, RF), Application (Surgical, Diagnostic, Forensic) - Forecasts to 2022
The global Tissue Dissection market is poised to witness sustainable growth during the forecast period. As the number of surgical & clinical procedures is increasing every year along with rising criminal cases (including murder, homicide, & rape) market demand for these instruments will continue to grow for related forensic applications, over next decade. Furthermore, the introduction of minimally invasive products for tissue dissection and increasing demand and adoption of these technologies in surgical procedures are expected to provide additional growth opportunities for the market growth.
- Published: January 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
